We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVAX icon
2776
Novavax
NVAX
$1.31B
$7K ﹤0.01%
1,249
-1,934
-61% -$15.2K
OBE
2777
Obsidian Energy
OBE
$662M
$7K ﹤0.01%
5,353
+4,353
+435% +$7.85K
ODP
2778
DELISTED
ODP
ODP
$7K ﹤0.01%
+355
New +$8.04K
PATK icon
2779
Patrick Industries
PATK
$2.85B
$7K ﹤0.01%
210
-666
-76% -$20.9K
PCY icon
2780
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
$7K ﹤0.01%
224
-776
-78% -$21.8K
PLNT icon
2781
Planet Fitness
PLNT
$3.78B
$7K ﹤0.01%
100
-928
-90% -$69.9K
PRGS icon
2782
Progress Software
PRGS
$1.76B
$7K ﹤0.01%
+160
New +$6.93K
PSHG icon
2783
Performance Shipping
PSHG
$21.8M
$7K ﹤0.01%
+47
New +$7.63K
RARE icon
2784
Ultragenyx Pharmaceutical
RARE
$2.55B
$7K ﹤0.01%
+110
New +$7K
RMNI icon
2785
Rimini Street
RMNI
$471M
$7K ﹤0.01%
1,398
+783
+127% +$3.95K
RNAC icon
2786
Cartesian Therapeutics
RNAC
$268M
$7K ﹤0.01%
+118
New +$8.04K
RWO icon
2787
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
$7K ﹤0.01%
+143
New +$7.14K
SGMO
2788
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7K ﹤0.01%
649
+388
+149% +$4.13K
SPEM icon
2789
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$7K ﹤0.01%
+205
New +$7.26K
TLPH icon
2790
Talphera
TLPH
$74.2M
$7K ﹤0.01%
130
-7
-5% -$420
TSEM icon
2791
Tower Semiconductor
TSEM
$28.5B
$7K ﹤0.01%
428
-14,510
-97% -$242K
VATE icon
2792
INNOVATE Corp
VATE
$165M
$7K ﹤0.01%
297
-430
-59% -$10.6K
VIRC icon
2793
Virco
VIRC
$96.3M
$7K ﹤0.01%
1,438
+764
+113% +$3.25K
VNET
2794
VNET Group
VNET
$2.09B
$7K ﹤0.01%
928
-4,797
-84% -$36.7K
WLYB icon
2795
John Wiley & Sons Class B
WLYB
$2.73B
$7K ﹤0.01%
154
XOMA
2796
DELISTED
Xoma
XOMA
$7K ﹤0.01%
485
-6,615
-93% -$99.3K
ZBH icon
2797
Zimmer Biomet
ZBH
$18.4B
$7K ﹤0.01%
60
-3,902
-98% -$457K
ZLAB icon
2798
Zai Lab
ZLAB
$2.62B
$7K ﹤0.01%
211
-1,943
-90% -$57.2K
FFNW
2799
DELISTED
First Financial Northwest, Inc
FFNW
$7K ﹤0.01%
464
+364
+364% +$5.71K
KA
2800
DELISTED
Kineta, Inc. Common Stock
KA
$7K ﹤0.01%
49
-1
-2% -$155

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.